Nafarelin Protocol — Complete Dosing & Administration Guide

Dosing

How muchdo I take?

Intranasal: Sprayed into the nose, where it absorbs through the nasal lining.

Bioavailability Moderate — absorbs through the nasal lining and can partly bypass the gut.

Standard Dose

400 mcg/day (one 200 mcg spray each nostril, AM and PM)

Frequency

Twice daily

Duration

6 months

FDA-labeled endometriosis dose; start between cycle days 2-4. May increase to 800 mcg/day if amenorrhea is not achieved after 2 months [6].

Advanced Dose

1600-1800 mcg/day (400 mcg per nostril dosing)

Twice daily (up to 3 times)

Until resumption of puberty is desired

FDA-labeled central precocious puberty dose: 1600 mcg/day standard, increasable to 1800 mcg/day [6].

Timing

Best time to take

Use Nafarelin at the same time each day for optimal results. Consistency in timing helps maintain stable levels and maximize therapeutic benefits. Follow your healthcare provider's specific instructions.

With food?

Nafarelin can generally be used with or without food. If you experience any discomfort, try taking it with a light meal. Follow specific guidance from your healthcare provider.

If stacking

Nafarelin should be used as directed by your healthcare provider. If combining with other medications or supplements, discuss potential interactions with your provider. Avoid combining with compounds that have overlapping mechanisms unless specifically guided by a medical professional.

Adjusting Your Dose

Increase if

+You've tolerated the current dose for the recommended period without significant side effects

+Therapeutic goals haven't been met at the current dose level

+Your healthcare provider recommends dose escalation based on your response

+Lab work or clinical assessments support a higher dose

Decrease if

-Side effects are bothersome or impacting daily life despite management strategies

-You experience any signs of an adverse reaction

-Lab results indicate the need for dose reduction

-Your healthcare provider recommends a lower dose based on your response

Signs of right dose

✓Therapeutic goals being met with minimal side effects

✓Stable and consistent response to treatment

✓Lab values or clinical markers trending in the right direction

✓Good tolerance with manageable or absent side effects

Dosing Calculator

Calculate Your Exact Dose

Step 1: Peptide Weight

Find the weight printed on your peptide vial label

Look here!

The peptide weight is printed on the label

The weight is on the label

Select Weight

Look for a number followed by 'mg' on the vial label (e.g., 5mg, 10mg)

Administration

How do Iuse it?

Reconstitution

What you need

•Nafarelin vial (lyophilized powder or solution)

•Bacteriostatic water or sterile sodium chloride for reconstitution

•Alcohol swabs for cleaning vial tops and injection sites

•Appropriately sized syringes with fine-gauge needles (27-30 gauge)

•Sharps disposal container

Example

Add the recommended volume of bacteriostatic water to the Nafarelin vial. Gently swirl (do not shake) until the powder is fully dissolved. The resulting solution should be clear. Calculate your individual dose based on the concentration and your prescribed amount.

Your dose of Nafarelin is determined by your healthcare provider. Using an insulin syringe marked in units, draw up the exact amount prescribed. For example, if the reconstituted concentration is 1mg/mL and your dose is 0.5mg, draw up 0.5mL (50 units on an insulin syringe). Always double-check calculations before injection.

Injection

Route

Subcutaneous injection (into the fatty tissue just under the skin)—allows for consistent absorption and can be self-administered at home after proper training

Best sites

•Abdomen (stomach area)—at least 2 inches from the belly button, most popular choice for self-injection

•Front of thighs—middle to upper portion of the outer leg

•Back of upper arm—outer area (may need assistance from another person)

Technique

1.Wash your hands thoroughly with soap and water before handling supplies

2.Clean the injection site with an alcohol swab and let it air dry completely

3.Pinch a fold of skin at the chosen injection site

4.Insert the needle at a 45-90 degree angle (depending on needle length and body composition)

5.Inject the medication slowly and steadily over 5-10 seconds

6.Release the skin fold and remove the needle, applying gentle pressure with a clean swab

7.Rotate injection sites to prevent tissue irritation or lipodystrophy

8.Dispose of the needle safely in a sharps container—never recap or reuse needles

Storage

Before reconstitution

Store Nafarelin in the refrigerator at 36-46°F (2-8°C) in its original packaging. Protect from light and moisture. Do not freeze. Check the expiration date before use. Some formulations may be stored at room temperature for limited periods—check your specific product labeling.

After reconstitution

Once reconstituted, Nafarelin should be kept refrigerated at 36-46°F (2-8°C) and used within the timeframe specified on your product labeling (typically 14-28 days). Label the vial with the reconstitution date. Do not use if the solution appears cloudy, discolored, or contains particles.

Signs of degradation

Solution appears cloudy, discolored, or contains visible particles (should be clear)

Product has been exposed to temperatures outside the recommended storage range

Product has been frozen (unless specifically designed for freeze-thaw stability)

Expiration date has passed or reconstituted solution has exceeded its use-by date

Unusual odor, color change, or visible contamination

Sample Daily Schedule

As prescribed (once daily)

As prescribed by your healthcare provider injection

Site: As directed by healthcare provider—rotate sites if applicable

Maintain a consistent schedule for optimal results with Nafarelin. Set reminders if needed. If you miss a dose, follow your healthcare provider's instructions—do not double up on doses to compensate.

Safety

Is itsafe?

Safety Profile

Nafarelin is FDA-approved with a well-established safety profile across decades of clinical use for endometriosis and precocious puberty. The most significant safety consideration is hypogonadism and bone density loss during prolonged therapy, requiring add-back therapy (norethindrone 0.4 mg daily) after 6 months to prevent osteoporosis. Common side effects—hot flashes, vaginal dryness, mood changes—are reversible upon discontinuation and typically diminish with continued use.

FDA approval based on multiple randomized controlled trials in endometriosis (n=1000+) showing superior efficacy versus danazol with improved tolerability. Long-term safety data from 20+ years of clinical use demonstrates Class III osteoporosis risk after 12 months without add-back therapy, measured via DEXA scans. Cardiovascular effects minimal; lipid profile changes are modest and reversible.

Common Side Effects

Experienced by some users

Hot flashes and night sweats (happen in 90% of users)

Management: Consult your healthcare provider for guidance.

Mood changes including depression or anxiety

Decreased sexual interest

Vaginal dryness

Headaches

Nasal irritation (if using spray formulation)

Breast tenderness

Muscle aches and joint pain

Weight gain or changes in body composition

Nausea and upset stomach

Sleep problems

Emotional sensitivity and mood swings

Allergic reactions (rare)

Significant bone density loss with extended use

Severe mood disorders requiring medical attention

Hot flashes (flushes of heat and redness)

Night sweats and chills

Vaginal dryness and discomfort

Mood depression or anxiety

Changes in sexual desire

Weight changes

Muscle and joint aches

Nasal irritation or sinus problems

Breast tenderness or swelling

Acne

Sleep disturbances

Nausea

Fatigue

Bone pain

Stop and Seek Help If

×Severe or worsening side effects that don't improve with dose adjustment or supportive care

×Signs of an allergic reaction—rash, hives, swelling, or difficulty breathing

×Your healthcare provider recommends discontinuation based on your clinical response

×Development of any new medical condition that may be contraindicated with Nafarelin

×Pregnancy or planning to become pregnant (unless specifically approved for use during pregnancy)

×Abnormal lab results or clinical markers that suggest adverse effects

Nafarelin should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.

Interactions

With other peptides

✓No known direct interaction with Nafarelin. BPC-157 is sometimes used for its gut-protective properties, which could theoretically help manage GI side effects.

With medications

✓Blood thinners (warfarin, heparin) - Monitor closely if combining with Nafarelin as interactions may affect bleeding risk or drug metabolism.

With supplements

✓Multivitamins - Generally safe to take alongside Nafarelin. Space doses apart if taking oral formulations to ensure optimal absorption.

✓Electrolyte supplements - Helpful if experiencing any GI side effects that could lead to dehydration. Safe to combine.

Want the Full Picture?

View the complete Nafarelin research profile including mechanism of action, clinical studies, effectiveness timeline, and FAQ.